Kim Kelderman is CEO at BIO-TECHNE Corp (TECH). They have made 6 open-market trades across 1 company since 2021, most recently 2026-09-08.
CIK 0001739054
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TECH | SELL | 2025-01-27 | 2025-01-29 | $77.28 | $2.1M | -3.8% | -15.0% | -30.5% |
| TECH | SELL | 2021-11-19 | 2021-11-23 | $505.38 | $253K | -0.4% | +5.2% | -14.9% |
| TECH | SELL | 2021-09-22 | 2021-09-24 | $529.04 | $870K | -9.7% | -4.6% | -7.6% |
| TECH | SELL | 2021-06-09 | 2021-06-11 | $433.00 | $351K | +0.1% | +1.7% | +14.5% |
| TECH | SELL | 2021-05-25 | 2021-05-27 | $424.00 | $358K | +4.4% | +8.3% | +21.7% |
| TECH | SELL | 2021-02-05 | 2021-02-09 | $388.45 | $639K | -4.1% | -1.3% | +3.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.